Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology

DISCUSSION: AD and LBPs modify risk factors for CAA and should be considered in reviewing the risk of CAA.HIGHLIGHTS: Lewy body pathology modifies risk factors for cerebral amyloid angiopathy (CAA) when present along with Alzheimer's disease (AD) neuropathology. In the context of anti-amyloid monoclonal therapies and their associated risks for hemorrhage, the risk of underlying CAA in mixed dementia with Lewy body pathology needs to be considered.PMID:38353367 | DOI:10.1002/alz.13704
Source: The Journal of Alzheimers Association - Category: Psychiatry Authors: Source Type: research